NCT06501417 EC_ItaLynch: Mainstreaming the Diagnosis of Lynch Syndrome Status NOT_YET_RECRUITING Phase N/A
NCT06486441 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06481592 A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. Status RECRUITING Phase PHASE2
NCT06475599 Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT06463028 Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer Status RECRUITING Phase PHASE2
NCT06409052 Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women Status RECRUITING Phase N/A
NCT06395519 A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT06385548 Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer Status WITHDRAWN Phase PHASE1/PHASE2
NCT06360653 a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer Status RECRUITING Phase NA
NCT06354738 Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment Status RECRUITING Phase NA
NCT06341855 Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer Status RECRUITING Phase NA
NCT06340568 A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer Status RECRUITING Phase PHASE3